Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-α1

Neoplasia

Volumn 3, Issue 2, 2001, Pages 154-164

  Ozawa, S ^a   Shinohara, H ^a   Kanayama, H O ^a   Bruns, C J ^a   Bucana, C D ^a   Ellis, L M ^a   Davis, D W ^a   Fidler, I J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Apoptosis; Interferon

Indexed keywords

ALPHA2A INTERFERON;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIVER METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

EID: 0035043493     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900128     Document Type: Article

References (69)

1. Cancer statistics
2. Clinical perspective on colorectal cancer
3. Critical factors in the biology of human cancer metastasis; twenty-eight GHA Clowes Memorial Award Lecture
4. The influence of the organ microenvironment on the expression of basic fibroblast growth factor in renal cell carcinoma cells
5. The role of angiogenesis in tumor growth
6. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
7. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice
8. Angiogenesis and metastasis
9. Progressive upregulation of metastasis-related genes in human colon cancer cells implanted into the cecum of nude mice
10. Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor
11. The implication of angiogenesis of biology and therapy of metastasis
12. Interferons alpha and beta downregulate the expression of basic fibroblast growth factor in human carcinomas
13. Virus interference. I. The interferon
14. The interferons: A biological system with therapeutic potential in viral infections
15. Role of interferons in the regulation of cell proliferation, differentiation, and development
16. Interferon -α-mediated downregulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule
17. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration
18. Human recombinant interferons-β and -γ decrease gelatinase production and invasion by human KG-2 renal carcinoma cells
19. Modulation of the invasive phenotype of human colon carcinoma cells by organ-specific fibroblasts of nude mice
20. Down-regulation of interleukin 8 gene expression in human fibroblasts: Unique mechanism of transcriptional inhibition by interferon
21. Interferon-β prevents the upregulation of interleukin-8 expression in human melanoma cells
22. Cytokine therapeutics: Lessons from interferon-α
23. Interferons in malignancy: Biological products or biological response modifiers?
24. Effects of interferons and other cytokines on tumors in animals: A review
25. Pharmacokinetics and pharmacodynamics of recombinant human interferon-β in health male volunteers
26. Why do so many cancer patients fail to respond to interferon therapy?
27. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma
28. In situ mRNA hybridization technique for analysis of metastasis-related gene in human colon carcinoma cells
29. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice
30. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice
31. Clonal stimulation or inhibition of human colon carcinomas mediated by transforming growth factor-α1
32. Spatial and temporal expression of angiogenic molecules during tumor growth and progression
33. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma
34. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice
35. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
36. Automated molecular pathology: One hour in situ DNA hybridization
37. Chemical synthesis and biological studies on mutated gene-control region
38. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas
39. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma
40. Complete one-hour immunocytochemistry based on capillary action
41. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma
42. Monoclonal antibodies specific for endothelial cells of mouse blood vessels: Their application in the identification of adult and embryonic endothelium
43. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma
44. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical application of research on angiogenesis
45. The implications of angiogenesis to the biology and therapy of cancer metastasis
46. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
47. Modulation of the organ microenvironment for the treatment of cancer metastasis
48. Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells
49. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
50. Tumor angiogenesis
51. Angiogenesis inhibition: A review
52. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: Balance between growth and death signals
53. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
54. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression
55. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation
56. Evaluation of low dose alpha-interferon (Roferon-A) in patients with advanced renal cell carcinoma: A Southwest Oncology Group study
57. Interferon α-2b adjuvant therapy of high risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
58. The interferons, mechanisms of action and clinical applications
59. Prospective randomized trial of two dose levels of interferon-α with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: A Canadian HIV Clinical Trials Network study
60. Interferon-alpha and survival in renal cell carcinoma
61. 5-Flurouracil and interferon-α in chemotherapy refractory bladder carcinoma: An effective regimen
62. Recombinant human interleukin-2, recombinant human interferon-α-2a, or both in metastatic renal cell carcinoma
63. Interferon treatments: How to use an endogenous system as a therapeutic agent
64. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: Higher efficacy of interferon-β
65. Interferon α-2a therapy for life-threatening hemangiomas of infancy
66. Interferon-α therapy of hemangiomas of infancy
67. Interferon-α-2a for the treatment of complex hemangiomas of infancy and childhood
68. Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a